Ubs Group Ag Invo Bioscience, Inc. Transaction History

Ubs Group Ag

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$0.16 - $0.64 $112 - $448	700 New	700 $0
Q4 2022 Feb 08, 2023	BUY	$0.39 - $28.0 $6,415 - $460,600	16,450 Added 204.73%	24,485 $10,000
Q3 2022 Nov 10, 2022	SELL	$0.77 - $23.2 $64,877 - $1.95 Million	-84,256 Reduced 91.29%	8,035 $9,000
Q2 2022 Aug 10, 2022	BUY	$0.64 - $2.66 $59,006 - $245,246	92,198 Added 99137.63%	92,291 $59,000
Q1 2022 May 16, 2022	SELL	$2.19 - $3.82 $411 - $718	-188 Reduced 66.9%	93 $0
Q4 2021 Feb 14, 2022	BUY	$2.93 - $4.19 $550 - $787	188 Added 202.15%	281 $1,000
Q2 2021 Aug 13, 2021	SELL	$3.71 - $5.18 $7,123 - $9,945	-1,920 Reduced 95.38%	93 $0
Q1 2021 May 12, 2021	SELL	$2.96 - $9.4 $12,964 - $41,172	-4,380 Reduced 68.51%	2,013 $8,000
Q4 2020 Feb 11, 2021	BUY	$3.0 - $9.47 $19,179 - $60,541	6,393 New	6,393 $19,000

14.1K

Ticker INVO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 12,169,700
Market Cap $9.74M
Description
INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.